199 related articles for article (PubMed ID: 34552593)
1. Enriched Environment Cues Suggest a New Strategy to Counteract Glioma: Engineered rAAV2-IL-15 Microglia Modulate the Tumor Microenvironment.
Mormino A; Bernardini G; Cocozza G; Corbi N; Passananti C; Santoni A; Limatola C; Garofalo S
Front Immunol; 2021; 12():730128. PubMed ID: 34552593
[TBL] [Abstract][Full Text] [Related]
2. Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study.
Kim K; Gwak HS; Han N; Hong EK; Choi BK; Lee S; Choi S; Park JH; Seok JH; Jeon Y; Cho H; Lee SJ; Lee Y; Nam KT; Song SW
Front Immunol; 2021; 12():715000. PubMed ID: 34819930
[TBL] [Abstract][Full Text] [Related]
3. AAV2-mediated interleukin-12 in the treatment of malignant brain tumors through activation of NK cells.
Chiu TL; Lin SZ; Hsieh WH; Peng CW
Int J Oncol; 2009 Dec; 35(6):1361-7. PubMed ID: 19885559
[TBL] [Abstract][Full Text] [Related]
4. Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice.
Garofalo S; D'Alessandro G; Chece G; Brau F; Maggi L; Rosa A; Porzia A; Mainiero F; Esposito V; Lauro C; Benigni G; Bernardini G; Santoni A; Limatola C
Nat Commun; 2015 Mar; 6():6623. PubMed ID: 25818172
[TBL] [Abstract][Full Text] [Related]
5. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.
Gong HX; He L; Li XP; Wang YD; Li Y; Huang JJ; Wang Z; Xie D; Kung HF; Peng Y
Oncol Rep; 2012 Apr; 27(4):1163-9. PubMed ID: 22210010
[TBL] [Abstract][Full Text] [Related]
6. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract][Full Text] [Related]
7. Environmental stimuli shape microglial plasticity in glioma.
Garofalo S; Porzia A; Mainiero F; Di Angelantonio S; Cortese B; Basilico B; Pagani F; Cignitti G; Chece G; Maggio R; Tremblay ME; Savage J; Bisht K; Esposito V; Bernardini G; Seyfried T; Mieczkowski J; Stepniak K; Kaminska B; Santoni A; Limatola C
Elife; 2017 Dec; 6():. PubMed ID: 29286001
[TBL] [Abstract][Full Text] [Related]
8. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
10. Self-sufficient primary natural killer cells engineered to express T cell receptors and interleukin-15 exhibit improved effector function and persistence.
van Hees EP; Morton LT; Remst DFG; Wouters AK; Van den Eynde A; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2024; 15():1368290. PubMed ID: 38690288
[TBL] [Abstract][Full Text] [Related]
11. PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma.
Wang XP; Guo W; Chen YF; Hong C; Ji J; Zhang XY; Dong YF; Sun XL
Int Immunopharmacol; 2024 May; 133():112074. PubMed ID: 38615383
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.
Carvalho da Fonseca AC; Wang H; Fan H; Chen X; Zhang I; Zhang L; Lima FR; Badie B
J Neuroimmunol; 2014 Sep; 274(1-2):71-7. PubMed ID: 25042352
[TBL] [Abstract][Full Text] [Related]
13. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
[TBL] [Abstract][Full Text] [Related]
14. Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12.
Yamanaka R; Tsuchiya N; Yajima N; Honma J; Hasegawa H; Tanaka R; Ramsey J; Blaese RM; Xanthopoulos KG
J Neurosurg; 2003 Oct; 99(4):746-53. PubMed ID: 14567611
[TBL] [Abstract][Full Text] [Related]
15. The treatment of glioblastoma multiforme through activation of microglia and TRAIL induced by rAAV2-mediated IL-12 in a syngeneic rat model.
Chiu TL; Wang MJ; Su CC
J Biomed Sci; 2012 Apr; 19(1):45. PubMed ID: 22520731
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice.
D'Alessandro G; Antonangeli F; Marrocco F; Porzia A; Lauro C; Santoni A; Limatola C
Eur J Immunol; 2020 May; 50(5):705-711. PubMed ID: 32034922
[TBL] [Abstract][Full Text] [Related]
18. Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.
Thaci B; Ahmed AU; Ulasov IV; Wainwright DA; Nigam P; Auffinger B; Tobias AL; Han Y; Zhang L; Moon KS; Lesniak MS
Cancer Gene Ther; 2014 Jan; 21(1):38-44. PubMed ID: 24434573
[TBL] [Abstract][Full Text] [Related]
19. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice.
Yiang GT; Harn HJ; Yu YL; Hu SC; Hung YT; Hsieh CJ; Lin SZ; Wei CW
J Biomed Sci; 2009 May; 16(1):47. PubMed ID: 19422685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
